These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23883667)

  • 1. β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.
    Nam JM; Ahmed KM; Costes S; Zhang H; Onodera Y; Olshen AB; Hatanaka KC; Kinoshita R; Ishikawa M; Sabe H; Shirato H; Park CC
    Breast Cancer Res; 2013; 15(4):R60. PubMed ID: 23883667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells.
    Ahmed KM; Zhang H; Park CC
    Cancer Res; 2013 Jun; 73(12):3737-48. PubMed ID: 23576567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.
    Park CC; Zhang HJ; Yao ES; Park CJ; Bissell MJ
    Cancer Res; 2008 Jun; 68(11):4398-405. PubMed ID: 18519702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
    Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
    BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.
    Allen MD; Thomas GJ; Clark S; Dawoud MM; Vallath S; Payne SJ; Gomm JJ; Dreger SA; Dickinson S; Edwards DR; Pennington CJ; Sestak I; Cuzick J; Marshall JF; Hart IR; Jones JL
    Clin Cancer Res; 2014 Jan; 20(2):344-57. PubMed ID: 24150233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
    Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
    Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation.
    Kambach DM; Sodi VL; Lelkes PI; Azizkhan-Clifford J; Reginato MJ
    Oncogene; 2014 Jan; 33(5):589-98. PubMed ID: 23318431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.
    Nam JM; Onodera Y; Bissell MJ; Park CC
    Cancer Res; 2010 Jul; 70(13):5238-48. PubMed ID: 20516121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
    Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
    Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-κB signaling pathways.
    Lian K; Ma C; Hao C; Li Y; Zhang N; Chen YH; Liu S
    Oncotarget; 2017 Jul; 8(30):48889-48904. PubMed ID: 28388580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy.
    Hong Y; Limback D; Elsarraj HS; Harper H; Haines H; Hansford H; Ricci M; Kaufman C; Wedlock E; Xu M; Zhang J; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Aripoli A; Huppe A; Balanoff C; Wagner JL; Amin AL; Larson KE; Ricci L; Tawfik O; Razek H; Meierotto RO; Madan R; Godwin AK; Thompson J; Hilsenbeck SG; Futreal A; Thompson A; Hwang ES; Fan F; Behbod F;
    J Pathol; 2022 Feb; 256(2):186-201. PubMed ID: 34714554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
    Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
    J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
    Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
    Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway.
    Montaseri A; Busch F; Mobasheri A; Buhrmann C; Aldinger C; Rad JS; Shakibaei M
    PLoS One; 2011; 6(12):e28663. PubMed ID: 22194879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer.
    Treekitkarnmongkol W; Shah V; Kai K; Katayama H; Wong J; Ladha FA; Nguyen T; Menegaz B; Lu W; Yang F; Mino B; Tang X; Gagea M; Batra H; Raso MG; Wistuba II; Krishnamurthy S; Pinder SE; Sawyer EJ; Thompson AM; Sen S
    Br J Cancer; 2024 Jul; 131(1):171-183. PubMed ID: 38760444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
    Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S
    Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus Inhibits the Progression of Ductal Carcinoma
    Chen G; Ding XF; Pressley K; Bouamar H; Wang B; Zheng G; Broome LE; Nazarullah A; Brenner AJ; Kaklamani V; Jatoi I; Sun LZ
    Clin Cancer Res; 2020 Mar; 26(6):1486-1496. PubMed ID: 31871301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation.
    Shah S; Brock EJ; Jackson RM; Ji K; Boerner JL; Sloane BF; Mattingly RR
    Neoplasia; 2018 Sep; 20(9):951-963. PubMed ID: 30144784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.